Quantcast
The first installment of our new predictive index shows that dealmakers expect overall M&A to increase, with health care outperforming the overall market READ MORE 

SLIDESHOW

ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld

Watercooler

GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market

Roundtable

Financial Services Companies Heat Up M&A Market
Speakers from Flexpoint Ford, Genstar Capital, Baird Capital, Madison Capital Funding and Katten Muchin Rosenman discuss the various factors playing a role in M&A activity within the financial services space

Expert's Corner

Pursuing Pharma Manufacturing
The fragmented pharmaceutical manufacturing industry provides plenty of opportunities for private equity investors, says JLL Partners founder Paul Levy

Today's Transactions:
Icon Acquires Cross Country Healthcare Division for $52M

The clinical-trial services division includes ClinForce, Assent Consulting and Akos

Icon plc (Nasdaq: ICLN) will acquire the clinical-trial services division of Cross Country Healthcare Inc. (Nasdaq: CCRN) for $52 million.

The clinical-trial services division includes ClinForce and Assent Consulting, which provide contract staffing, permanent placement and other services. The division also includes Akos, a provider of drug-safety services.

Icon may pay an additional $3.75 million depending on the performance of the division.

Dublin-based Icon provides outsourcing services to pharmaceutical, biotechnology and medical device companies.

Cross Country, headquartered in Boca Raton, Fla., is a healthcare staffing company. 

 

For more information on related topics, visit the following: